Cinkarna Celje stock holds steady as investors eye latest results

Published on 09/19/2026 at 19:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cinkarna Celje stock remains stable on the Ljubljana Stock Exchange as of September 19, 2026, while investors digest the company’s most recent annual results. The latest figures highlight revenue growth and solid profitability compared with the previous year.

Cinkarna Celje, SICICG000005, Illustration mit AI erstellt.

Cinkarna Celje stock (ISIN SICICG000005) is trading steadily on the Ljubljana Stock Exchange as of September 19, 2026, with investors focusing on the company’s most recently reported full-year figures and the outlook for its specialty chemicals and titanium dioxide business.

Latest available fundamentals support valuation

According to Cinkarna Celje’s latest published annual report for fiscal year 2025, the company generated revenue in the low hundreds of millions of euros, marking a clear increase compared with fiscal year 2024 and underscoring resilient demand in its core product segments.

In the same fiscal year 2025, Cinkarna Celje reported a solid net profit, with net margin improving versus the prior year, reflecting a combination of firmer pricing, disciplined cost control and a favorable product mix in pigments and other chemical products.

Profitability trends and comparison with prior year

The fiscal year 2025 results show that Cinkarna Celje’s revenue rose by a double-digit percent compared with fiscal year 2024, while net profit climbed at an even faster rate, resulting in a visibly higher net margin year on year.

Historical figures from fiscal year 2024 indicate that Cinkarna Celje’s revenue and earnings were meaningfully lower, so the latest annual numbers highlight a clear improvement in operating performance and give investors a reference point when assessing the stock’s current valuation.

Stock price level and market indicators

On the Ljubljana Stock Exchange, Cinkarna Celje stock last closed close to the middle of its 52-week trading range, signaling a balanced investor view as of mid-September 2026; based on recent data, the share price stands comfortably above the 52-week low but still clearly below the 52-week high, leaving room for potential upside if earnings momentum continues.

As of September 19, 2026, the company’s market capitalization, calculated from the latest available share price and shares outstanding, is in the low hundreds of millions of euros, placing Cinkarna Celje firmly in the mid-cap segment of the regional market and making it a notable, but not dominant, player in European specialty chemicals.

Closing price perspective for retail investors

For retail investors, the key takeaway is that Cinkarna Celje stock currently trades at a level that reflects improved profitability versus fiscal year 2024 while remaining below the 52-week high, suggesting that the market has acknowledged the stronger results but has not fully priced in the potential for continued earnings strength.